Aclaris Therapeutics Announces Leadership Transition
Provided By GlobeNewswire
Last update: Jul 28, 2025
- Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer -
- Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as Part of Planned Retirement -
Read more at globenewswire.com
